13C CPMAS NRM and molecular modeling in the studies of new analogues of buspirone

Acta Poloniae Pharmaceutica - Drug Research

Volumn 59, Issue 6, 2002, Pages 461-465

  Pisklak, Maciej ^a   Perliński, Mirosław ^a   Kossakowski, Jerzy ^a   Wawer, Iwona ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Buspirone analogues; CPMAS NMR; Solid state NMR

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; CARBON; DRUG ANALOG; LIGAND; PROTON; SEROTONIN 1 RECEPTOR; DRUG DERIVATIVE;

ANISOTROPY; ARTICLE; CALCULATION; CARBON NUCLEAR MAGNETIC RESONANCE; CROSS REACTION; DRUG CONFORMATION; DRUG MECHANISM; DRUG STRUCTURE; METHODOLOGY; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID STATE; TRANQUILIZING ACTIVITY; X RAY DIFFRACTION; ARTIFICIAL NEURAL NETWORK; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

ANTI-ANXIETY AGENTS; BUSPIRONE; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; NEURAL NETWORKS (COMPUTER);

EID: 0036870849     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Goa K., Ward A.: Drugs, 32, 114 (1986).
2. Kossakowski J., Maleszewska E.: Acta Polon. Pharm.-Drug Res. 57 (Suppl), 47 (2002).
3. Kossakowski J., Maleszewska E.: Acta Polon. Pharm.-Drug Res. 57 (Suppl), 50 (2002).
4. Hyperchem 5.01 for Windows95, Hypercube Inc., Canada.
5. Gaussian 98, Revision A.7, Gaussian, Inc., Pittsburgh PA 1998.
6. Holzgrabe U., Wawer I., Diehl B.: in NMR Spectroscopy in Drug Development and Analysis, Wiley-VCH Ed., Chapter 12, Weinheim. 1999.
7. Szelejewska-Woźniakowska A., Chilmończyk Z., Leś A., Wawer I.: Solid State NMR 13, 63 (1998).
8. Szelejewska-Woźniakowska A., Chilmończyk Z., Leś A., Wawer I.: Solid State NMR 14, 59 (1999).